None
EN
Beta-Blocker Use in HF and AF: Insights from India's Landmark ROBUST Study
['Prem Aggarwal', 'Written', 'Hiremath Js', 'Dasbiswas A', 'Sawhney Jps', 'Chandra S', 'Mohanan Pp', 'Srivastava S', 'Nath B.']
Medical News, Health News Latest, Medical News Today - Medical Dialogues |
Beta-blockers have long been a cornerstone in the management of cardiovascular diseases, particularly heart failure (HF) and atrial fibrillation (AF).
Beta-Blockers Continue to Play a Central Role in Heart FailureThe ROBUST survey reaffirms the importance of beta-blockers in heart failure management.
• Low heart rate and low blood pressure were the most common reasons for withholding beta-blocker therapy in heart failure.
Its cardioselective profile and favourable tolerability are particularly useful in patients with coexisting heart failure, coronary disease or respiratory comorbidities."
AbbreviationsHF- Heart Failure; AF- Atrial Fibrillation; JAPI- Journal of the Association of Physicians of India; HCP- Health-Care Professionals; HFrEF- Heart Failure with Reduced Ejection Fraction